Hot Life Science Investor Mandate 2: Venture Fund Plans to Make Opportunistic Allocations Over 1st Half of 2013 – February 27, 2013

26 Feb

A venture fund headquartered in the Eastern US, which specializes in early stage opportunities in med-tech, diagnostics, and instruments, currently has an AUM of more than $30 million. Typically, the firm initially invests in a start-up at the early stage, but reserves capital for participation later on. First investments are usually in the range of $1-3 million, but they are open to making larger or smaller allocations as opportunities arise.

The firm expects to invest a total in the range of $10 million in a given portfolio company as it makes progress toward a successful exit. They prefer to be the lead investor in any deals that they engage in, and plan to make several allocations on an opportunistic basis over the first half of 2013.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s

%d bloggers like this: